Ali Ozes

Ali Ozes is the Founder and CEO of Altay Therapeutics, a company focused on developing specific and safer therapies to extend patients' lives.1 He holds a Ph.D. and is described as an experienced scientist and entrepreneur with a passion for cutting-edge research and drug development.2

Professional Background

Dr. Ozes founded Altay Therapeutics in 2019 with his co-founder Osman Ozes.3 Prior to establishing Altay, he worked as a Scientist at Nalo Therapeutics.5 His expertise lies in transcription factor biology and clinical drug development.1

Education and Skills

Ali Ozes completed his Ph.D. in Molecular and Cellular Biology.5 He has also participated in the Creative Destruction Lab program, which likely contributed to his entrepreneurial skills.2

Company Leadership

At Altay Therapeutics, Dr. Ozes leads a team of scientists who employ an integrated approach to drug development. This approach combines biochemical assays, next-generation computational biology, and chemoproteomics.1 As the CEO, he is responsible for guiding the company's mission and overseeing its operations.

Research Focus

Dr. Ozes's work at Altay Therapeutics is centered on developing novel therapeutics with the potential to save millions of lives.4 The company's research appears to be particularly relevant to FSH (Facioscapulohumeral) Research, as indicated by his involvement with the Friends of FSH Research organization.3

Ali Ozes is based in San Bruno, California, and continues to lead Altay Therapeutics in its pursuit of innovative drug development strategies.6